Issue 37.17
Diabetes is a largely misunderstood disease even among those who have been diagnosed. A better understanding can help us prevent and control this disease.
Type 2 diabetes is the most common form of diabetes. This form of diabetes starts with our body’s improper use of insulin and progresses until we are unable to produce enough insulin to keep our blood glucose at normal levels.
Although diabetes is a serious disease, it can be controlled. Lifestyle modifications are an important and essential component to controlling diabetes. Weight loss, diet, and exercise are three very important lifestyle modifications.
Participating in research is a great way to become informed while playing a significant role in the development and progression of treatment for diabetes. Participants in clinical research are the “front-line” champions in the medical world. Every life-saving treatment started with a volunteer.
Our area is fortunate to have several physician groups conducting a variety of clinical trials to improve treatment in several therapeutic areas. Chrysalis Clinical Research coordinates research for physician groups.
Our ongoing diabetes trials include both insulin and non-insulin therapies. These trials provide great education and a solid foundation for patients to build on. All trial related materials, tests, procedures, medications, and trial related visits with the doctor and research team are free for participants. Participants will gain a better understanding of diabetes and how to appropriately manage it with both medication and lifestyle modifications. Participants will be educated by physicians, nurses, pharmacists, and dieticians.
In addition to diabetes, Chrysalis Clinical Research is enrolling patients in studies for high blood pressure and high cholesterol, osteoarthritis of the knee, Meniere’s disease, shingles, and inflammatory bowel disease with constipation.
For more information or to see if you might qualify for a clinical trial and help us bring new innovative drugs/devices to market contact Chrysalis Clinical Research at 435 656 1704 or visit our webpage www: sgccr.com.